Biolife solutions announces leadership transitions & preliminary third quarter revenue with updated outlook for 2023

Roderick de greef appointed chairman and chief executive officer bringing 20+ years of prior biolife experience garrie richardson appointed chief revenue officer preliminary q3 revenue of $33.3 million and expect 2023 revenue at the low end of the previously announced guidance range  bothell, wash. , oct. 19, 2023 /prnewswire/ --  biolife solutions , inc. (nasdaq: blfs ), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy (cgt) and broader biopharma markets, today announced roderick de greef has been appointed as chairman of the board of directors and chief executive officer replacing michael rice who is retiring after a seventeen year tenure, effective immediately.
BLFS Ratings Summary
BLFS Quant Ranking